https://news.cision.comCision is the leading global provider of media research, distribution, monitoring and evaluation services. With over 40 locations throughout the world, Cision provides the insight, expertise and intelligence that improve performance and build reputations.Tue, 09 Jun 2026 08:50:32 GMT14660https://news.cision.comhttps://news.cision.com/Content/img/news-logo.pnghttps://news.cision.com/genovis-ab/r/interim-report-january-september-2024,c4062725cision4934540Fri, 08 Nov 2024 07:00:00 GMThttps://news.cision.com/genovis-ab/r/genovis-launches-fabricator--xtra--next-generation-enzyme-for-future-antibody-therapeutics,c4041442cision4904574Mon, 23 Sep 2024 13:00:00 GMThttps://news.cision.com/genovis-ab/r/half-yearly-report-january---june-2024,c4025320cision4883454Tue, 20 Aug 2024 06:00:00 GMThttps://news.cision.com/genovis-ab/r/genovis-announces-strategic-divestment-of-antibody-business-to-leinco-technologies-inc-,c4026050cision4883349Mon, 19 Aug 2024 17:00:00 GMThttps://news.cision.com/genovis-ab/r/genovis-completes-a-strategic-investment-in-sequrna--a-developer-of-next-generation-rnase-inhibitors,c4011493cision4863790Thu, 04 Jul 2024 12:45:00 GMThttps://news.cision.com/genovis-ab/r/communique-from-genovis-ab--publ--annual-general-meeting-may-15--2024,c3982390cision4824482Wed, 15 May 2024 16:54:00 GMThttps://news.cision.com/genovis-ab/r/interim-report-january---march-2024,c3976051cision4824163Wed, 15 May 2024 13:00:00 GMThttps://news.cision.com/genovis-ab/r/genovis-annual-report-2023-published,c3966157cision4803057Wed, 24 Apr 2024 06:00:00 GMThttps://news.cision.com/genovis-ab/r/notice-convening-the-2024-annual-general-meeting,c3958589cision4791562Tue, 09 Apr 2024 10:00:00 GMThttps://news.cision.com/genovis-ab/r/carthesian-therapeutics-terminates-genovis-licence-agreement,c3946311cision4774490Thu, 14 Mar 2024 16:25:46 GMThttps://news.cision.com/genovis-ab/r/year-end-report-january-december-2023,c3927763cision4750751Thu, 15 Feb 2024 07:00:00 GMThttps://news.cision.com/genovis-ab/r/genovis-to-receive-usd-1-million-in-milestone-compensation-related-to-the-development-of-the-xork--e,c3927387cision4748612Tue, 13 Feb 2024 07:20:00 GMThttps://news.cision.com/genovis-ab/r/genovis-ab-changes-certified-adviser-to-carnegie-investment-bank-ab--publ-,c3885165cision4692768Thu, 30 Nov 2023 07:00:00 GMThttps://news.cision.com/genovis-ab/r/interim-report-january-september-2023,c3875015cision4680867Wed, 15 Nov 2023 07:00:00 GMThttps://news.cision.com/genovis-ab/r/half-yearly-report-january-june-2023,c3820614cision4610835Thu, 24 Aug 2023 06:00:00 GMThttps://news.cision.com/genovis-ab/r/genovis-launch-innovative-igm-specific-protease-with-wide-ranging-applications-in-life-science-marke,c3779328cision4554338Fri, 02 Jun 2023 08:30:00 GMThttps://news.cision.com/genovis-ab/r/communique-from-genovis-ab--publ--annual-general-meeting-may-16--2023,c3770940cision4542437Tue, 16 May 2023 16:33:19 GMThttps://news.cision.com/genovis-ab/r/interim-report-january-march-2023,c3767176cision4541346Tue, 16 May 2023 06:00:00 GMThttps://news.cision.com/genovis-ab/r/genovis-and-arcticzymes-technologies-enter-into-a-collaboration-agreement-to-accelerate-growth-in-ch,c3762802cision4531423Wed, 03 May 2023 11:00:00 GMThttps://news.cision.com/genovis-ab/r/genovis-acquires-ip-rights-to-novel-enzymes-for-applications-within-genomics,c3757723cision4524423Tue, 25 Apr 2023 13:00:00 GMThttps://news.cision.com/genovis-ab/r/genovis-annual-report-2022-published,c3757438cision4524140Tue, 25 Apr 2023 09:15:00 GMThttps://news.cision.com/genovis-ab/r/notice-convening-the-2023-annual-general-meeting,c3748957cision4512261Tue, 11 Apr 2023 10:30:00 GMThttps://news.cision.com/genovis-ab/r/year-end-report-january-december-2022,c3712684cision4466480Wed, 15 Feb 2023 07:00:00 GMThttps://news.cision.com/genovis-ab/r/genovis-to-receive-4-musd-upfront-after-selecta-biosciences-sublicensed-xork--enzyme-to-astellas-pha,c3694675cision4440023Mon, 09 Jan 2023 12:57:56 GMT